Stock Talk · by Zeynep Demir · 2026-09-21

LLY is expensive and I still understand why people keep paying up

This is one of those names where 'too expensive' has been true in some abstract spreadsheet sense for what feels like forever, and yet the business keeps handing the market new reasons to stay excited. Obesity, pipeline depth, execution, all of it.

I don't own it because I hate buying greatness after everybody already agrees it's great. But I no longer do the smug thing where I call it obvious overvaluation and move on.

17 sparks · 6 comments

Comments

Urban Baker · 3 likes

My boomer uncle has owned it since before I knew what GLP-1 meant and he will mention this on his deathbed.

Avery Johnson · 2 likes

My biggest investing pain is confusing 'too high for me' with 'too high for the market.'

Noé Petit · 2 likes

There are expensive stocks and then there are expensive businesses with a line outside the store.

Cozy Panda · 1 likes

I bought a tiny tracker position just so I would stop hate-watching it.

Zeynep Demir · 1 likes

That is a very honest portfolio construction technique.

Liam Wilson · 0 likes

Pipeline plus execution gets a premium. People underestimate how rare both at once are in pharma.